UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): December 16, 2024

 

ASP Isotopes Inc.

(Exact name of registrant as specified in its charter)

 

Delaware

 

001-41555

 

87-2618235

(State or other jurisdiction of

incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

601 Pennsylvania Avenue NW,

South Building, Suite 900

Washington, DC

 

20004

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code: (202) 756-2245

 

 Not Applicable

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐ 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐ 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Ticker symbol(s)

 

Name of each exchange on which registered

Common Stock, par value $0.01

 

ASPI

 

The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act   ☐

 

 

 

 

Item 7.01. Regulation FD Disclosure.

 

On December 16, 2024, ASP Isotopes Inc. (the “Company”) issued a letter to shareholders which summarizes the more significant milestones the Company has achieved during 2024 and discusses future goals for 2025. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference.

 

The information in this Item 7.01, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

 

Item 9.01. Financial Statements and Exhibits.

 

Exhibit No.

 

Description

99.1

 

ASP Isotopes Inc. Letter to Shareholders, dated December 16, 2024.

104

 

Cover Page Interactive Date File (embedded within the Inline XBRL document)

 

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

ASP ISOTOPES INC.

 

 

 

 

Date: December 16, 2024

By:

/s/ Paul Mann

 

 

Name:

Paul Mann

 

 

Title:

Chief Executive Officer

 

 

 

3

 

nullv3.24.4
Cover
Dec. 16, 2024
Cover [Abstract]  
Entity Registrant Name ASP Isotopes Inc.
Entity Central Index Key 0001921865
Document Type 8-K
Amendment Flag false
Entity Emerging Growth Company true
Document Period End Date Dec. 16, 2024
Entity Ex Transition Period false
Entity File Number 001-41555
Entity Incorporation State Country Code DE
Entity Tax Identification Number 87-2618235
Entity Address Address Line 1 601 Pennsylvania Avenue NW
Entity Address Address Line 2 South Building
Entity Address Address Line 3 Suite 900
Entity Address City Or Town Washington
Entity Address State Or Province DC
Entity Address Postal Zip Code 20004
City Area Code 202
Local Phone Number 756-2245
Security 12b Title Common Stock, par value $0.01
Trading Symbol ASPI
Security Exchange Name NASDAQ
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
ASP Isotopes (NASDAQ:ASPI)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more ASP Isotopes Charts.
ASP Isotopes (NASDAQ:ASPI)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more ASP Isotopes Charts.